Suppr超能文献

采用互补方法分析聚乙二醇化纳米颗粒上的血浆蛋白吸附:二维电泳、毛细管电泳和蛋白质芯片系统。

Analysis of plasma protein adsorption onto PEGylated nanoparticles by complementary methods: 2-DE, CE and Protein Lab-on-chip system.

作者信息

Kim Hyun Ryoung, Andrieux Karine, Delomenie Claudine, Chacun Héléne, Appel Martine, Desmaële Didier, Taran Fréderic, Georgin Dominique, Couvreur Patrick, Taverna Myriam

机构信息

Laboratory of Pharmaceutical Technology, University of Paris-Sud, Châtenay-Malabry, France.

出版信息

Electrophoresis. 2007 Jul;28(13):2252-61. doi: 10.1002/elps.200600694.

Abstract

The biodistribution of colloidal carriers after their administration in vivo depends on the adsorption of some plasma proteins and apolipoproteins on their surface. Poly(methoxypolyethyleneglycol cyanoacrylate-co-hexadecylcyanoacrylate) (PEG-PHDCA) nanoparticles have demonstrated their capacity to cross the blood-brain barrier (BBB) by a mechanism of endocytosis. In order to clarify this mechanism at the molecular level, proteins and especially apolipoproteins adsorbed at the surface of PEG-PHDCA nanoparticles were analyzed by complementary methods such as CE and Protein Lab-on-chip in comparison with 2-D PAGE as a method of reference. Thus, the ability of those methodologies to identify and quantify human and rat plasma protein adsorption onto PEG-PHDCA nanoparticles and conventional PHDCA nanoparticles was evaluated. The lower adsorption of proteins onto PEG-PHDCA nanoparticles comparatively to PHDCA nanoparticles was evidenced by 2-D PAGE and Protein Lab-on-chip methods. CE allowed the quantification of adsorbed proteins without the requirement of a desorption procedure but failed, in this context, to analyze complex mixtures of proteins. The Protein Lab-on-chip method appeared to be very useful to follow the kinetic of protein adsorption from serum onto nanoparticles; it was complementary to 2-D PAGE which allowed the identification (with a relative quantification) of the adsorbed proteins. The overall results suggest the implication of the apolipoprotein E in the mechanism of passage of PEG-PHDCA nanoparticles through the BBB.

摘要

胶体载体在体内给药后的生物分布取决于其表面吸附的一些血浆蛋白和载脂蛋白。聚(甲氧基聚乙二醇氰基丙烯酸酯 - 共 - 十六烷基氰基丙烯酸酯)(PEG - PHDCA)纳米颗粒已通过内吞作用机制证明了其穿越血脑屏障(BBB)的能力。为了在分子水平上阐明这一机制,通过与作为参考方法的二维聚丙烯酰胺凝胶电泳(2 - D PAGE)等互补方法,分析了吸附在PEG - PHDCA纳米颗粒表面的蛋白质,尤其是载脂蛋白。因此,评估了这些方法识别和定量人及大鼠血浆蛋白吸附到PEG - PHDCA纳米颗粒和传统PHDCA纳米颗粒上的能力。二维聚丙烯酰胺凝胶电泳和芯片上蛋白质分析方法证明,与PHDCA纳米颗粒相比,蛋白质在PEG - PHDCA纳米颗粒上的吸附较少。毛细管电泳(CE)无需解吸程序即可对吸附的蛋白质进行定量,但在此情况下无法分析复杂的蛋白质混合物。芯片上蛋白质分析方法似乎对于跟踪蛋白质从血清吸附到纳米颗粒上的动力学非常有用;它是二维聚丙烯酰胺凝胶电泳的补充,二维聚丙烯酰胺凝胶电泳可对吸附的蛋白质进行鉴定(相对定量)。总体结果表明载脂蛋白E参与了PEG - PHDCA纳米颗粒穿越血脑屏障的机制。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验